nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—kidney cancer—nephrolithiasis	0.885	1	CtDrD
Capecitabine—Neck oedema of—Hydrochlorothiazide—nephrolithiasis	0.0204	0.188	CcSEcCtD
Capecitabine—Localised oedema—Hydrochlorothiazide—nephrolithiasis	0.00386	0.0357	CcSEcCtD
Capecitabine—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.00252	0.0232	CcSEcCtD
Capecitabine—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.00199	0.0184	CcSEcCtD
Capecitabine—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.00186	0.0171	CcSEcCtD
Capecitabine—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00159	0.0146	CcSEcCtD
Capecitabine—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0142	CcSEcCtD
Capecitabine—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00152	0.014	CcSEcCtD
Capecitabine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0118	CcSEcCtD
Capecitabine—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00124	0.0115	CcSEcCtD
Capecitabine—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00109	0.01	CcSEcCtD
Capecitabine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00997	CcSEcCtD
Capecitabine—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00971	CcSEcCtD
Capecitabine—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00102	0.0094	CcSEcCtD
Capecitabine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.000994	0.00917	CcSEcCtD
Capecitabine—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.000892	0.00823	CcSEcCtD
Capecitabine—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00814	CcSEcCtD
Capecitabine—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00814	CcSEcCtD
Capecitabine—DPYD—Nucleotide metabolism—APRT—nephrolithiasis	0.00084	0.201	CbGpPWpGaD
Capecitabine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.000819	0.00755	CcSEcCtD
Capecitabine—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.000815	0.00752	CcSEcCtD
Capecitabine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000807	0.00745	CcSEcCtD
Capecitabine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.000807	0.00745	CcSEcCtD
Capecitabine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.000803	0.00741	CcSEcCtD
Capecitabine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0008	0.00738	CcSEcCtD
Capecitabine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.000792	0.00731	CcSEcCtD
Capecitabine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000785	0.00724	CcSEcCtD
Capecitabine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.000764	0.00705	CcSEcCtD
Capecitabine—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.000758	0.00699	CcSEcCtD
Capecitabine—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.000754	0.00696	CcSEcCtD
Capecitabine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.000751	0.00693	CcSEcCtD
Capecitabine—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.000751	0.00693	CcSEcCtD
Capecitabine—CDA—Nucleotide metabolism—APRT—nephrolithiasis	0.000749	0.179	CbGpPWpGaD
Capecitabine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.000748	0.0069	CcSEcCtD
Capecitabine—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.000745	0.00687	CcSEcCtD
Capecitabine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000745	0.00687	CcSEcCtD
Capecitabine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000735	0.00678	CcSEcCtD
Capecitabine—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.000729	0.00673	CcSEcCtD
Capecitabine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000712	0.00656	CcSEcCtD
Capecitabine—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.000709	0.00654	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000709	0.00654	CcSEcCtD
Capecitabine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.000703	0.00649	CcSEcCtD
Capecitabine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.000698	0.00643	CcSEcCtD
Capecitabine—DPYD—nephron tubule—nephrolithiasis	0.000696	0.245	CbGeAlD
Capecitabine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.000684	0.00631	CcSEcCtD
Capecitabine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.000671	0.00619	CcSEcCtD
Capecitabine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000666	0.00615	CcSEcCtD
Capecitabine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.000664	0.00612	CcSEcCtD
Capecitabine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.000654	0.00604	CcSEcCtD
Capecitabine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00065	0.00599	CcSEcCtD
Capecitabine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.000647	0.00597	CcSEcCtD
Capecitabine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000647	0.00597	CcSEcCtD
Capecitabine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000645	0.00595	CcSEcCtD
Capecitabine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00064	0.00591	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000638	0.00589	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000638	0.00589	CcSEcCtD
Capecitabine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000627	0.00579	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00577	CcSEcCtD
Capecitabine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00577	CcSEcCtD
Capecitabine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000617	0.00569	CcSEcCtD
Capecitabine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.000613	0.00565	CcSEcCtD
Capecitabine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000613	0.00565	CcSEcCtD
Capecitabine—TYMP—Nucleotide metabolism—APRT—nephrolithiasis	0.000599	0.143	CbGpPWpGaD
Capecitabine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000597	0.0055	CcSEcCtD
Capecitabine—DPYD—cortex of kidney—nephrolithiasis	0.000596	0.21	CbGeAlD
Capecitabine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000573	0.00528	CcSEcCtD
Capecitabine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.000573	0.00528	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000569	0.00525	CcSEcCtD
Capecitabine—CYP2C9—urine—nephrolithiasis	0.000561	0.198	CbGeAlD
Capecitabine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000559	0.00516	CcSEcCtD
Capecitabine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000557	0.00514	CcSEcCtD
Capecitabine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000553	0.0051	CcSEcCtD
Capecitabine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000549	0.00507	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000541	0.00499	CcSEcCtD
Capecitabine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.000538	0.00497	CcSEcCtD
Capecitabine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000537	0.00495	CcSEcCtD
Capecitabine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.000535	0.00494	CcSEcCtD
Capecitabine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.000535	0.00494	CcSEcCtD
Capecitabine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000532	0.00491	CcSEcCtD
Capecitabine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000531	0.0049	CcSEcCtD
Capecitabine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000531	0.0049	CcSEcCtD
Capecitabine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000521	0.0048	CcSEcCtD
Capecitabine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000515	0.00475	CcSEcCtD
Capecitabine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00051	0.0047	CcSEcCtD
Capecitabine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000499	0.0046	CcSEcCtD
Capecitabine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000492	0.00453	CcSEcCtD
Capecitabine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00049	0.00452	CcSEcCtD
Capecitabine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000488	0.0045	CcSEcCtD
Capecitabine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000487	0.00449	CcSEcCtD
Capecitabine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00446	CcSEcCtD
Capecitabine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000472	0.00436	CcSEcCtD
Capecitabine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000464	0.00428	CcSEcCtD
Capecitabine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000457	0.00422	CcSEcCtD
Capecitabine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000455	0.0042	CcSEcCtD
Capecitabine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000438	0.00404	CcSEcCtD
Capecitabine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000433	0.004	CcSEcCtD
Capecitabine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000427	0.00394	CcSEcCtD
Capecitabine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000421	0.00388	CcSEcCtD
Capecitabine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000418	0.00386	CcSEcCtD
Capecitabine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000413	0.00381	CcSEcCtD
Capecitabine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00041	0.00379	CcSEcCtD
Capecitabine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000402	0.00371	CcSEcCtD
Capecitabine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0004	0.00369	CcSEcCtD
Capecitabine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000396	0.00365	CcSEcCtD
Capecitabine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00364	CcSEcCtD
Capecitabine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000385	0.00355	CcSEcCtD
Capecitabine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000383	0.00354	CcSEcCtD
Capecitabine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000383	0.00353	CcSEcCtD
Capecitabine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00352	CcSEcCtD
Capecitabine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000377	0.00348	CcSEcCtD
Capecitabine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000375	0.00346	CcSEcCtD
Capecitabine—Cough—Hydrochlorothiazide—nephrolithiasis	0.000372	0.00344	CcSEcCtD
Capecitabine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000363	0.00335	CcSEcCtD
Capecitabine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000363	0.00335	CcSEcCtD
Capecitabine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000363	0.00335	CcSEcCtD
Capecitabine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000362	0.00334	CcSEcCtD
Capecitabine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000359	0.00331	CcSEcCtD
Capecitabine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000355	0.00328	CcSEcCtD
Capecitabine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000351	0.00324	CcSEcCtD
Capecitabine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000348	0.00321	CcSEcCtD
Capecitabine—TYMS—nephron tubule—nephrolithiasis	0.000346	0.122	CbGeAlD
Capecitabine—TYMP—cortex of kidney—nephrolithiasis	0.000345	0.122	CbGeAlD
Capecitabine—Shock—Hydrochlorothiazide—nephrolithiasis	0.000343	0.00316	CcSEcCtD
Capecitabine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000341	0.00315	CcSEcCtD
Capecitabine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00034	0.00314	CcSEcCtD
Capecitabine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000337	0.00311	CcSEcCtD
Capecitabine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000332	0.00306	CcSEcCtD
Capecitabine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000325	0.003	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000317	0.00293	CcSEcCtD
Capecitabine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000315	0.00291	CcSEcCtD
Capecitabine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000313	0.00289	CcSEcCtD
Capecitabine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000311	0.00286	CcSEcCtD
Capecitabine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000307	0.00283	CcSEcCtD
Capecitabine—TYMS—Nucleotide metabolism—APRT—nephrolithiasis	0.000306	0.0733	CbGpPWpGaD
Capecitabine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000303	0.00279	CcSEcCtD
Capecitabine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0003	0.00277	CcSEcCtD
Capecitabine—Pain—Hydrochlorothiazide—nephrolithiasis	0.000298	0.00275	CcSEcCtD
Capecitabine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000298	0.00275	CcSEcCtD
Capecitabine—TYMS—cortex of kidney—nephrolithiasis	0.000296	0.104	CbGeAlD
Capecitabine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000287	0.00265	CcSEcCtD
Capecitabine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000285	0.00263	CcSEcCtD
Capecitabine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000277	0.00255	CcSEcCtD
Capecitabine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000275	0.00254	CcSEcCtD
Capecitabine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000275	0.00254	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—SLC2A9—nephrolithiasis	0.000267	0.0639	CbGpPWpGaD
Capecitabine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000257	0.00237	CcSEcCtD
Capecitabine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00025	0.00231	CcSEcCtD
Capecitabine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000246	0.00227	CcSEcCtD
Capecitabine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000238	0.0022	CcSEcCtD
Capecitabine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00023	0.00212	CcSEcCtD
Capecitabine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000221	0.00204	CcSEcCtD
Capecitabine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00022	0.00203	CcSEcCtD
Capecitabine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000219	0.00202	CcSEcCtD
Capecitabine—Headache—Hydrochlorothiazide—nephrolithiasis	0.000218	0.00201	CcSEcCtD
Capecitabine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000207	0.00191	CcSEcCtD
Capecitabine—DPYD—Metabolism—GRHPR—nephrolithiasis	0.000101	0.0241	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GRHPR—nephrolithiasis	8.97e-05	0.0215	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AGXT—nephrolithiasis	8.97e-05	0.0215	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AGXT—nephrolithiasis	8e-05	0.0191	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC26A1—nephrolithiasis	7.63e-05	0.0183	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APRT—nephrolithiasis	7.63e-05	0.0183	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GRHPR—nephrolithiasis	7.17e-05	0.0172	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC26A1—nephrolithiasis	6.8e-05	0.0163	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APRT—nephrolithiasis	6.8e-05	0.0163	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AGXT—nephrolithiasis	6.39e-05	0.0153	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APRT—nephrolithiasis	5.44e-05	0.013	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC26A1—nephrolithiasis	5.44e-05	0.013	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AQP1—nephrolithiasis	5.44e-05	0.013	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CHRM3—nephrolithiasis	4.92e-05	0.0118	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AQP1—nephrolithiasis	4.85e-05	0.0116	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	4.69e-05	0.0112	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CHRM3—nephrolithiasis	4.38e-05	0.0105	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AQP1—nephrolithiasis	3.87e-05	0.00927	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GRHPR—nephrolithiasis	3.67e-05	0.00878	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CHRM3—nephrolithiasis	3.5e-05	0.00838	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AGXT—nephrolithiasis	3.27e-05	0.00783	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC26A1—nephrolithiasis	2.78e-05	0.00665	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APRT—nephrolithiasis	2.78e-05	0.00665	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AQP1—nephrolithiasis	1.98e-05	0.00474	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CHRM3—nephrolithiasis	1.79e-05	0.00429	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	1.06e-05	0.00253	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AGXT—nephrolithiasis	9.43e-06	0.00226	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APRT—nephrolithiasis	8.02e-06	0.00192	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	8.02e-06	0.00192	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AQP1—nephrolithiasis	5.71e-06	0.00137	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	5.17e-06	0.00124	CbGpPWpGaD
